Abstract
Knock-in of the BCL2 G101V Mutation in Human iPSC-Derived NK Cells Generates Venetoclax Resistance and Improves Activity Against Venetoclax Resistant AML
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have